SHUBHAM PANT to Tumor Microenvironment
This is a "connection" page, showing publications SHUBHAM PANT has written about Tumor Microenvironment.
Connection Strength
0.214
-
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors. Invest New Drugs. 2022 10; 40(5):990-1000.
Score: 0.100
-
Immunotherapy in Gastrointestinal Malignancies. Adv Exp Med Biol. 2021; 1342:259-272.
Score: 0.090
-
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study. J Immunother Cancer. 2022 01; 10(1).
Score: 0.024